CV9202 is a self-adjuvanting mRNA-based vaccine encoding six NSCLC-associated antigens: mucin 1 (MUC1), survivin, NY-ESO-1, 5T4 oncofetal antigen, and MAGE-C1 and MAGE-C2. Here, BIRC5 is linked to non-small cell lung carcinoma.